Skip to content

Plain-English explainer

Semaglutide Dosing & Side Effects: A Plain Guide

Explained by Sofia Mendez, Patient Education Editor

We keep this plain-English — no jargon, every claim sourced.

Almost everyone starting semaglutide asks the same two questions: how much do I take, and is it going to make me feel sick? The honest answer to both is tied together, because the whole point of the dosing schedule is to keep side effects manageable. Here is how it works, in plain language and tied to the FDA label.

You start low and go slow

You do not begin at the full dose. The FDA prescribing information for Wegovy lays out a step-up schedule: you start at 0.25 mg once weekly and increase roughly every four weeks — through 0.5 mg, 1.0 mg, and 1.7 mg — up to the 2.4 mg weekly maintenance dose1. Ozempic, the type 2 diabetes version, follows a similar path: 0.25 mg to start, then 0.5 mg, then up to 1.0 or 2.0 mg weekly2. The 0.25 mg starting dose is a "warm-up" dose — it is not expected to do much on its own; its job is to let your body adjust.

This gradual climb is not an accident or a sales tactic. The STEP 1 weight-loss trial used the same 16-week dose escalation to reach the maintenance dose, precisely because easing in improves tolerability3. If side effects flare when you step up, prescribers often hold you at your current dose longer before increasing again.

Step by step
Per the FDA prescribing information for Wegovy. Your prescriber may hold any step longer if side effects need more time to settle — the schedule is a guide, not a deadline.

The common side effects, and why they happen

The most common side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These come from the same mechanism that makes the medicine work — semaglutide slows how fast your stomach empties and acts on appetite signals, so feeling full quickly or a little queasy is the flip side of eating less4. That same slowed-stomach effect is also behind the extra burping and reflux some people notice, which we explain in "Ozempic burps" & acid reflux. A pooled analysis across the SUSTAIN diabetes trials characterized this profile in detail5.

Two reassuring points from that same body of evidence. First, these symptoms are usually worst early and around dose increases, and they tend to ease as your body adapts. Second — and this surprises people — the pooled SUSTAIN analysis found that weight loss happened even in patients who did not experience GI side effects, so you do not have to feel sick for the medicine to work5. (Early nausea is also the single most common complaint in Wegovy reviews — and, like the trial data, it usually eases.) The goal is a good result with tolerable, not maximal, side effects6.

Beyond the gut, a less common but much-discussed reaction is hair shedding — about 3% in the Wegovy trials, and almost always temporary telogen effluvium driven by the rapid weight loss rather than the drug itself. We unpack why it happens and whether it grows back in does semaglutide cause hair loss?.

Practical ways to manage GI symptoms

While this is general education and not medical advice for your situation, the commonly recommended, label-consistent strategies are straightforward. Eat smaller portions and stop when you feel full rather than pushing through. Favor blander, lower-fat foods when nausea hits, and stay hydrated, especially if you have diarrhea or vomiting. Our what to eat on Wegovy guide turns this into a full protein-first eating framework. Give each dose level time before stepping up, and tell your prescriber if symptoms are severe or not improving — they can slow the titration or hold the dose. For a deeper, symptom-by-symptom playbook, see Wegovy constipation & diarrhea: managing GI side effects. The label and your clinician are the right reference for your specific plan1.

If a dose increase hits hard

It is common to feel fine at one dose and then notice a wave of nausea after stepping up — that is the most predictable moment for side effects, because each increase asks your gut to adjust again. The fix is usually not to push through at all costs. Prescribers frequently hold you at your current dose for an extra few weeks, or in some cases step back down briefly, before trying the increase again. There is no prize for reaching the maintenance dose fastest; the SUSTAIN program data show the medicine works across a range of people, and the priority is landing on a dose you can live with6. This slow ramp is also why weight loss takes months to fully show up — we lay out that whole arc in when does Wegovy start working?. The escalation schedule on the label is a default, not a deadline1. The same go-low-go-slow logic applies if you are arriving from a different drug entirely: switching from Zepbound to Wegovy means re-titrating from a low dose, because tirzepatide and semaglutide are different molecules with no one-to-one dose conversion.

Side effects that need a clinician, not a workaround

Most GI symptoms are a nuisance that fades. But some warrant prompt medical attention. The FDA label carries a boxed warning about thyroid C-cell tumors based on rodent studies, and lists contraindications including a personal or family history of medullary thyroid carcinoma — which is part of why semaglutide is prescription-only and screened before you start1. Severe, persistent abdominal pain, signs of dehydration, or symptoms that do not settle are reasons to contact your clinician rather than tough it out. Dehydration matters here because it is the main pathway by which GI side effects can stress the kidneys, and severe upper-right abdominal pain can signal a gallbladder problem — both are covered in semaglutide and your gallbladder/kidneys. Semaglutide also modestly raises resting heart rate as a labeled class effect, and dehydration can amplify the palpitations some people feel — we explain when that's benign and when to seek care in does Wegovy or Ozempic raise heart rate?. This is exactly why titration and monitoring happen under medical supervision.

The bottom line on dosing

Semaglutide's dosing is built around one idea: reach an effective dose slowly enough that your gut can keep up. Start at 0.25 mg, step up roughly monthly, expect the most GI side effects early and at increases, and lean on your prescriber to adjust the pace if needed. Done this way, most people settle into a maintenance dose they tolerate. A steady pace has a cosmetic upside too: because facial hollowing — "Ozempic face" — tracks with how fast you lose fat, not racing to the highest dose gives your skin and soft tissue more time to adapt. If you are also figuring out the mechanics of the weekly shot itself, our step-by-step on how to inject Wegovy covers the pen, the vial, injection sites, and storage, and where's the best place to inject semaglutide? digs into abdomen-vs-thigh-vs-arm and why rotation matters. For the full evidence picture — efficacy, heart benefits, and the ongoing-use reality — see our pillar guide, Semaglutide: How It Works, Results & Side Effects, and the comparison of forms in Oral vs Injectable Semaglutide.

A few more quick ones

What is the semaglutide dose schedule?

For Wegovy, the FDA label describes starting at 0.25 mg once weekly and increasing about every four weeks through 0.5, 1.0, and 1.7 mg up to a 2.4 mg maintenance dose. Ozempic titrates from 0.25 mg up to 1.0 or 2.0 mg weekly. Your prescriber sets and adjusts your schedule.

How long do the side effects last?

Gastrointestinal side effects like nausea are usually worst early and around dose increases, and they tend to ease as your body adapts. Pooled trial data show weight loss occurs even in people who do not get GI side effects, so feeling sick is not required for the medicine to work.

What can I do about nausea on semaglutide?

Common, label-consistent strategies include eating smaller portions, stopping when full, choosing blander lower-fat foods, staying hydrated, and giving each dose level time before stepping up. Tell your prescriber if symptoms are severe — they can slow the titration. This is general education, not advice for your specific case.

When should I call my doctor about side effects?

Contact your clinician for severe or persistent abdominal pain, signs of dehydration, or symptoms that do not settle. Semaglutide's FDA label also carries a boxed warning about thyroid C-cell tumors and contraindications, which is why it is prescription-only and monitored.

Where this comes from

Every claim above traces back to one of these — real studies and official labeling.

  1. Novo Nordisk Pharmaceutical Industries, LP (2026). WEGOVY (semaglutide) injection, solution / tablet — FDA Prescribing Information (DailyMed). DailyMed (NLM). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. Novo Nordisk Pharmaceutical Industries, LP (2026). OZEMPIC (semaglutide) injection, solution — FDA Prescribing Information (DailyMed). DailyMed (NLM). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  3. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — titration methodology. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
  4. Drucker DJ (2022). GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab. https://pubmed.ncbi.nlm.nih.gov/34626851/
  5. Ahrén B, Atkin SL, Charpentier G, et al. (2018). Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/29766634/
  6. DeVries JH, Desouza C, Bellary S, et al. (2018). Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/29862621/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Keep exploring